Alfentanil
- Atc Codes:N01AH02
- CAS Codes:70879-28-6#69049-06-5#71195-58-9
- PHARMGKB ID:70879-28-6#69049-06-5#71195-58-9
Table of contents
- Brand Names
- Chemistry
- Pharmacologic Category
- Mechanism of Action
- Therapeutic Use
- Contraindications
- Warnings and Precautions
- Adverse Reactions
- Caution and personalized dose adjustment in patients with the following genotypes
- Other genes that may be involved
- Substrate of
- Drug Interactions
- Dosage
- Pharmacokinetics and Pharmacodynamics
- Special Considerations
Brand Names
Europe
Austria: Rapifen; Belgium: Rapifen; Czech Republic: Rapifen; Denmark: Rapifen; Finland: Rapifen; France: Rapifen; Germany: Alfentanil, Rapifen; Ireland: Rapifen; Italy: Fentalim; Luxembourg: Rapifen; Netherlands: Rapifen; Poland: Rapifen; Portugal: Rapifen; Spain: Limifén; Sweden: Rapifen; UK: Alfentanil, Rapifen.
North America
Canada: Alfentanil; USA: Alfenta, Alfentanil.
Latin America
Argentina: Brevafén; Brazil: Alfast, Rapifen; Mexico: Rapifén.
Drug combinations
Chemistry
Alfentanil Hydrochloride: C~21~H~32~N~6~O~3~.HCl.H~2~O. Mw: 470.99. (1) Propanamide, N-[1-[2-(4-ethyl-4,5-dihydro-5-oxo-1H-tetrazol-1-yl)ethyl]-4-(methoxymethyl)-4-piperidinyl]-N-phenyl, monohydrochloride, monohydrate; (2) N-[1-[2-(4-Ethyl-5-oxo-2-tetrazolin-1-yl)-ethyl]-4-(methoxymethyl)-4-piperidyl]propionanilide monohydrochloride monohydrate. CAS-70879-28-6; CAS-69049-06-5 (anhydrous); CAS-71195-58-9 (alfentanil)(1980).

Pharmacologic Category
Analgesics and Antipyretics; Opiate Agonists. Anilidopiperidine Opioid. (ATC-Code: N01AH02).
Mechanism of action
Increases pain threshold, alters pain perception and inhibits ascending pain pathways by binding with stereospecific receptors in the CNS. Ultra short-acting narcotic.
Therapeutic use
Analgesic adjunct in maintenance of anesthesia with barbiturate or N~2~O. As a primary anesthetic agent in general surgery in which endotracheal intubation and mechanical ventilation are required.
Pregnancy and lactiation implications
Unlabeled use
Contraindications
Hypersensitivity to alfentanil hydrochloride, narcotics or any component of the formulation. Increased intracranial pressure. Severe respiratory depression.
Warnings and precautions
May cause hypotension (use with caution in hypovolemia, cardiovascular disease (including acute myocardial infarction), or drugs which may exaggerate hypotensive effects (including phenothiazines or general anesthetics)). Opioid agonist toxicities. Caution when administering to patients with bradyarrhythmias. Potential for drug dependency exists. Exaggerated elevation of intracranial pressure may occur (use with extreme caution in head injury, intracranial lesions, or elevated intracranial pressure). Caution in morbidly obese patients. Use with caution in the following situations: respiratory disease (hypoxia and/or hypercapnia), chronic obstructive pulmonary disease or other obstructive pulmonary disease, and kyphoscoliosis or other skeletal disorder which may alter respiratory function). Hypotension has occurred in neonates with respiratory distress syndrome. Rapid intravenous infusion may result in skeletal muscle and chest wall rigidity, impaired ventilation, or respiratory distress/arrest.